PubRank

Sverre Erik Kjeldsen

Author PubWeight™ 20.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007 6.10
2 European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007 2.70
3 Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery. Am Heart J 2012 2.66
4 Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). Am J Cardiol 2008 1.92
5 [Hypertension in healthy people over 80 should be treated]. Tidsskr Nor Laegeforen 2013 1.59
6 [Choice of drug in hypertension]. Tidsskr Nor Laegeforen 2013 1.57
7 Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia. Metabolism 2007 1.42
8 Cardiovascular protection for all individuals at high risk: evidence-based best practice. Clin Res Cardiol 2008 0.86
9 Personality may influence reactivity to stress. Biopsychosoc Med 2007 0.84
10 The effect of antihypertensive agents on new-onset diabetes mellitus: time to amend the guidelines? Am J Cardiovasc Drugs 2006 0.78
11 A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients. Cardiology 2005 0.77
12 N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy. Cardiology 2006 0.75
13 Effects on plasma noradrenaline may explain some of the improved insulin sensitivity seen by AT-1 receptor blockade. Blood Press 2008 0.75
14 Complications of hypertension and the role of angiotensin receptor blockers in hypertension trials. Expert Rev Cardiovasc Ther 2007 0.75